A Breakthrough in Bone Health Assessment
UltraScan 650 provides direct BMD measurement without ionizing radiation, offering a safe and efficient alternative to DXA for screening and monitoring.
Key Advantages
-
FDA‑approved for clinical bone assessment
-
DXA‑equivalent accuracy BMD measurement without radiation
-
Under 10‑second measurement time
-
Compact & lightweight, USB-powered portable design
-
Intuitive touchscreen interface
-
Automated measurement workflow
-
Ideal for primary care, endocrinology, and women’s health
Patented Net Time Delay (NTD) Technology
Unlike conventional ultrasound devices that estimate bone density indirectly, UltraScan 650 uses CyberLogic’s NTD Technology to measure bone mineral density directly.
Clinical Benefits
-
High precision for longitudinal monitoring
-
Reliable results across diverse patient populations
-
Minimal operator training required
-
Comfortable, non‑invasive procedure
-
Print a report of BMD at the 1/3 radius and the T-score and z-score
Designed for Modern Preventive Medicine
UltraScan 650 supports a wide range of clinical environments:
-
Primary care & family medicine
-
Endocrinology & metabolic bone clinics
-
Women’s health & menopause centers
-
Community screening programs for osteoporosis
-
Mobile health services
Proven in Peer‑Reviewed Studies
UltraScan 650 has been validated in multiple clinical trials demonstrating:
-
Strong correlation with DXA
-
High reproducibility
-
Excellent sensitivity for low bone density detection
[See Quick Links below for more information]